BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23998568)

  • 1. [Myeloid/natural killer cell acute leukemia resembling acute promyelocytic leukemia].
    Wang JN; Hou YQ; Zhang LB; Bao HY; Song M; Meng QQ; Fu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):830-4. PubMed ID: 23998568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S; Meyerson H; Skallerud G; Rosenthal N
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cell-surface antigens in acute promyelocytic leukaemia.
    Paietta E
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):369-85. PubMed ID: 12935957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urgent states in hematology: acute promyelocytic leukemia--principles of diagnosis].
    Schwarz J; Kacírková P; Marková J; Mikulenková D; Marinov I; Ballingová I; Michalová K
    Vnitr Lek; 2008; 54(7-8):728-44. PubMed ID: 18780572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia with hypergranular cytoplasm: a differential diagnosis of acute promyelocytic leukemia.
    Girodon F; Carli PM; Favre B; Mannone L; Houssaye S; Mugneret F; Casasnovas O; Maynadié M
    Leuk Res; 2000 Nov; 24(11):979-82. PubMed ID: 11086183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
    Liu Y; Chen YT; Li JX; Zhang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):806-11. PubMed ID: 22931633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
    Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
    Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
    Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W
    Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?
    Fenu S; Carmini D; Mancini F; Guglielmi C; Alimena G; Riccioni R; Barsotti P; Mancini M; Avvisati G; Mandelli F
    Leuk Lymphoma; 1995; 18 Suppl 1():49-55. PubMed ID: 7496355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
    Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
    Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid/NK cell acute leukemia.
    Chen B; Xu X; Ji M; Lin G
    Int J Hematol; 2009 Apr; 89(3):365-367. PubMed ID: 19326059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
    Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
    Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR antigen-positive acute promyelocytic leukemia.
    Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
    Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.